Citation Impact
Citing Papers
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
2000
Coiled-Coil Motif as a Structural Basis for the Interaction of HTLV Type 1 Tax with Cellular Cofactors
2000
The DNA-damage response in human biology and disease
2009 StandoutNature
Profile of hepatocellular carcinoma in India: An insight into the possible etiologic associations
2001
Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis
2006
New therapies on the horizon for hepatitis C
2003 StandoutNobel
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Hepatitis C Virus Infection
2001 Standout
The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells
2004
International trends and patterns of primary liver cancer
2001
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
1999 Standout
Genetic instabilities in human cancers
1998 StandoutNature
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Design and development of polymers for gene delivery
2005 Standout
Genetic and epigenetic inactivation of tax gene in adult T‐cell leukemia cells
2004
Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha
2001
NF-κB-inducing Kinase and IκB Kinase Participate in Human T-cell Leukemia Virus I Tax-mediated NF-κB Activation
1998
A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients
2005
Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand
1999
Management of Hepatocellular Carcinoma *
2005 Standout
Molecular mechanisms of cellular transformation by HTLV-1 Tax
2005
Regulation of Gene Expression by HTLV-I Tax Protein
1998
Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-Apoptosis
1996 Standout
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
2011 StandoutNobel
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
STATs in oncogenesis
2000 Standout
Chronic hepatitis B
2007 Standout
Functional Interaction between the Mouse Notch1 Intracellular Region and Histone Acetyltransferases PCAF and GCN5
2000 StandoutNobel
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
2004 StandoutNobel
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
ALCOHOL AND CANCER
2004
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Tumor necrosis factor signaling
2003 Standout
Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas
1995 Standout
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
1997
Signaling to NF-κB
2004 Standout
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls
1999 Standout
β-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection
1999
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
Function and Activation of NF-kappaB in the Immune System
1994 Standout
Human T Cell Leukemia Virus Type 1 Oncoprotein Tax Targets the Human Mitotic Checkpoint Protein MAD1
1998
Negative control elements of the cell cycle in human tumors
1998 StandoutNobel
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action
1998
Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein
1992
Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression
1999
Hepatitis C Virus Internal Ribosome Entry Site (IRES) Stem Loop IIId Contains a Phylogenetically Conserved GGG Triplet Essential for Translation and IRES Folding
2000 StandoutNobel
Stable growth transformation of human T lymphocytes by herpesvirus saimiri.
1992
Gene Therapy for Infectious Diseases
1998
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
The HCV IRES pseudoknot positions the initiation codon on the 40S ribosomal subunit
2010 StandoutNobel
JAKS AND STATS: Biological Implications
1998 Standout
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Anaphase-Promoting Complex/Cyclosome–Dependent Proteolysis of Human Cyclin a Starts at the Beginning of Mitosis and Is Not Subject to the Spindle Assembly Checkpoint
2001 StandoutNobel
Wnt signaling and cancer
2000 Standout
Tumorigenicity of human T-cell leukemia virus type I-infected cell lines in severe combined immunodeficient mice and characterization of the cells proliferating in vivo
1995
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Constitutively Activated Jak-STAT Pathway in T Cells Transformed with HTLV-I
1995 Science
Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription
1997 StandoutNobel
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
1997 Standout
PCAF Interacts with Tax and Stimulates Tax Transactivation in a Histone Acetyltransferase-Independent Manner
1999
Antioxidant and redox regulation of gene transcription
1996 Standout
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
2000 Standout
HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.
1996
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
1996
Works of M. Alt being referenced
Persistence of Selectable Herpesvirus Saimiri in Various Human Haematopoietic and Epithelial Cell Lines
1991
Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides*1
1995
Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture
1992
Specific inhibition of hepatitis C viral gene expression: Antisense phosphorothioate oligodeoxynucleotides
1995
Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.
1996